Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Authors

Libi Hertzberg

Published

November 25, 2009

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Journal

Blood

Topics

Biology

Immunology

Hematology

Public Health, Environmental And Occupational Health

Germinal Center

DOI

10.1182/blood-2009-08-235408

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Authors

Libi Hertzberg

Published

November 25, 2009

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Journal

Blood

Topics

Biology

Immunology

Hematology

Public Health, Environmental And Occupational Health

Germinal Center

DOI

10.1182/blood-2009-08-235408

Paper

Paper

Paper

Paper

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Supporters

Journal

Topics

DOI

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Supporters

Journal

Topics

DOI